Why a US-funded vaccine trial on babies was cancelled in Guinea-Bissau
Some public health experts argued that the proposed trial raised broader questions about whether vulnerable populations in African countries were being asked to take risks that researchers would not accept in wealthier countries.
Read original article on Nilepost News →